Google Cloud Launches Artificial Intelligence Tools to Accelerate Drug Discovery and Precision Medic
On May 16, Google Cloud announced two new artificial intelligence life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical companies and public sector organizations. One, called Target and Lead Identification Suite, is now available globally to help researchers better identify the function of amino acids and predict the structure of proteins; the other, called Multiomics Suite, accelerates the discovery and interpretation of genomic data to help companies design precise therapies.
Tags: AIGoogle cloud
Previous: WHO: Careful use of artificial intelligence in healthcare Previous: What does the leaked Google AI memo really imply?
Related Articles
-
AI has over 1.7 million app installs in less than a week
-
"Father of ChatGPT" and other industry leaders jointly warn: AI may bring the risk of human extincti
-
Father of ChatGPT Warns AI Could Exterminate Humanity
-
A senior U.S. attorney using ChatGPT to assist with a case turned out to be a fake?
-
Smart home industry will usher in a new opportunity for development under the AI wave
-
ChatGPT will have a push on the smart home industry
Comments
Great Review